193 related articles for article (PubMed ID: 32002539)
1. RNA-seq reveals novel mechanistic targets of withaferin A in prostate cancer cells.
Kim SH; Hahm ER; Singh KB; Shiva S; Stewart-Ornstein J; Singh SV
Carcinogenesis; 2020 Jul; 41(6):778-789. PubMed ID: 32002539
[TBL] [Abstract][Full Text] [Related]
2. Cytoprotective autophagy induction by withaferin A in prostate cancer cells involves GABARAPL1.
Hahm ER; Singh SV
Mol Carcinog; 2020 Oct; 59(10):1105-1115. PubMed ID: 32743846
[TBL] [Abstract][Full Text] [Related]
3.
Kim SH; Singh KB; Hahm ER; Lokeshwar BL; Singh SV
J Tradit Complement Med; 2020 May; 10(3):188-197. PubMed ID: 32670813
[TBL] [Abstract][Full Text] [Related]
4. Withaferin A Inhibits Fatty Acid Synthesis in Rat Mammary Tumors.
Singh KB; Hahm ER; Kim SH; Singh SV
Cancer Prev Res (Phila); 2023 Jan; 16(1):5-16. PubMed ID: 36251722
[TBL] [Abstract][Full Text] [Related]
5. Leelamine Is a Novel Lipogenesis Inhibitor in Prostate Cancer Cells
Singh KB; Hahm ER; Pore SK; Singh SV
Mol Cancer Ther; 2019 Oct; 18(10):1800-1810. PubMed ID: 31395683
[TBL] [Abstract][Full Text] [Related]
6. RNA-seq reveals novel cancer-selective and disease subtype-independent mechanistic targets of withaferin A in human breast cancer cells.
Hahm ER; Kim SH; Singh KB; Singh SV
Mol Carcinog; 2021 Jan; 60(1):3-14. PubMed ID: 33150660
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism.
Singh KB; Kim SH; Hahm ER; Pore SK; Jacobs BL; Singh SV
Carcinogenesis; 2018 May; 39(6):826-837. PubMed ID: 29668854
[TBL] [Abstract][Full Text] [Related]
8. Fatty Acid Synthesis Intermediates Represent Novel Noninvasive Biomarkers of Prostate Cancer Chemoprevention by Phenethyl Isothiocyanate.
Singh KB; Singh SV
Cancer Prev Res (Phila); 2017 May; 10(5):279-289. PubMed ID: 28292742
[TBL] [Abstract][Full Text] [Related]
9. Withaferin A suppresses the up-regulation of acetyl-coA carboxylase 1 and skin tumor formation in a skin carcinogenesis mouse model.
Li W; Zhang C; Du H; Huang V; Sun B; Harris JP; Richardson Q; Shen X; Jin R; Li G; Kevil CG; Gu X; Shi R; Zhao Y
Mol Carcinog; 2016 Nov; 55(11):1739-1746. PubMed ID: 26472150
[TBL] [Abstract][Full Text] [Related]
10. Mammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cells.
Kim SH; Singh SV
Cancer Prev Res (Phila); 2014 Jul; 7(7):738-47. PubMed ID: 24824039
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells.
Szarc vel Szic K; Op de Beeck K; Ratman D; Wouters A; Beck IM; Declerck K; Heyninck K; Fransen E; Bracke M; De Bosscher K; Lardon F; Van Camp G; Vanden Berghe W
PLoS One; 2014; 9(2):e87850. PubMed ID: 24498382
[TBL] [Abstract][Full Text] [Related]
12. The Role of Forkhead Box Q1 Transcription Factor in Anticancer Effects of Withaferin A in Breast Cancer.
Kim SH; Singh KB; Hahm ER; Singh SV
Cancer Prev Res (Phila); 2021 Apr; 14(4):421-432. PubMed ID: 33509807
[TBL] [Abstract][Full Text] [Related]
13. A novel metabolic function of Myc in regulation of fatty acid synthesis in prostate cancer.
Singh KB; Hahm ER; Kim SH; Wendell SG; Singh SV
Oncogene; 2021 Jan; 40(3):592-602. PubMed ID: 33199826
[TBL] [Abstract][Full Text] [Related]
14. SILAC-based quantitative MS approach reveals Withaferin A regulated proteins in prostate cancer.
Kumar R; Nayak D; Somasekharan SP
J Proteomics; 2021 Sep; 247():104334. PubMed ID: 34298187
[TBL] [Abstract][Full Text] [Related]
15. Withaferin A Induces Cell Death Selectively in Androgen-Independent Prostate Cancer Cells but Not in Normal Fibroblast Cells.
Nishikawa Y; Okuzaki D; Fukushima K; Mukai S; Ohno S; Ozaki Y; Yabuta N; Nojima H
PLoS One; 2015; 10(7):e0134137. PubMed ID: 26230090
[TBL] [Abstract][Full Text] [Related]
16. Proteomic characterization of Withaferin A-targeted protein networks for the treatment of monoclonal myeloma gammopathies.
Dom M; Offner F; Vanden Berghe W; Van Ostade X
J Proteomics; 2018 May; 179():17-29. PubMed ID: 29448055
[TBL] [Abstract][Full Text] [Related]
17. Different effects of 4β-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells.
Wang HC; Hu HH; Chang FR; Tsai JY; Kuo CY; Wu YC; Wu CC
Phytomedicine; 2019 Feb; 53():213-222. PubMed ID: 30668401
[TBL] [Abstract][Full Text] [Related]
18. Reversal of the Warburg phenomenon in chemoprevention of prostate cancer by sulforaphane.
Singh KB; Hahm ER; Alumkal JJ; Foley LM; Hitchens TK; Shiva SS; Parikh RA; Jacobs BL; Singh SV
Carcinogenesis; 2019 Dec; 40(12):1545-1556. PubMed ID: 31555797
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.
Iannelli F; Roca MS; Lombardi R; Ciardiello C; Grumetti L; De Rienzo S; Moccia T; Vitagliano C; Sorice A; Costantini S; Milone MR; Pucci B; Leone A; Di Gennaro E; Mancini R; Ciliberto G; Bruzzese F; Budillon A
J Exp Clin Cancer Res; 2020 Oct; 39(1):213. PubMed ID: 33032653
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of withaferin A inhibits carcinogenesis of prostate in TRAMP model.
Suman S; Das TP; Moselhy J; Pal D; Kolluru V; Alatassi H; Ankem MK; Damodaran C
Oncotarget; 2016 Aug; 7(33):53751-53761. PubMed ID: 27447565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
